{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T07:41:32Z","timestamp":1725694892455},"publisher-location":"Berlin, Heidelberg","reference-count":27,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"type":"print","value":"9783642712906"},{"type":"electronic","value":"9783642712883"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1987]]},"DOI":"10.1007\/978-3-642-71288-3_29","type":"book-chapter","created":{"date-parts":[[2012,7,28]],"date-time":"2012-07-28T19:32:34Z","timestamp":1343503954000},"page":"248-254","source":"Crossref","is-referenced-by-count":2,"title":["Biochemical Alterations Produced by Neuroleptics in Man: Studies of Plasma Homovanillic Acid in Schizophrenic Patients"],"prefix":"10.1007","author":[{"given":"D.","family":"Pickar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O. M.","family":"Wolkowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Labarca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. R.","family":"Doran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Breier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. M.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"29_CR1","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1176\/ajp.135.4.500-a","volume":"135","author":"R Abrams","year":"1978","unstructured":"Abrams R, Taylor MA (1978) A rating scale for emotional blunting. Am J Psychiatry 135: 226\u2013229","journal-title":"Am J Psychiatry"},{"key":"29_CR2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0014-2999(79)90175-4","volume":"56","author":"NG Bacopoulos","year":"1979","unstructured":"Bacopoulos NG, Hattox SE, Roth RH (1979) 3,4-dihydroxyphenylacetic acid and homovanillic acid in rat plasma: possible indicators of central dopaminergic activity. Eur J Pharmacol 56: 225\u2013236","journal-title":"Eur J Pharmacol"},{"key":"29_CR3","first-page":"391","volume-title":"The pharmacologic basis of therapeutics","author":"RJ Baldessarini","year":"1980","unstructured":"Baldessarini RJ (1980) Drugs and the treatment of psychiatric disorders. In: Gilman AG, Goodman LS, Gilman A (eds) The pharmacologic basis of therapeutics. McMillan, New York, pp 391\u2013447"},{"key":"29_CR4","first-page":"53","volume":"35","author":"MJ Bannon","year":"1983","unstructured":"Bannon MJ, Roth RH (1983) Pharmacology of mesocortical dopamine neurons. Pharmacol Rev 35: 53\u201368","journal-title":"Pharmacol Rev"},{"key":"29_CR5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF00422751","volume":"28","author":"MB Bowers","year":"1973","unstructured":"Bowers MB Jr (1973) 5-HIAA and HVA following probenecid in acute psychotic patients treated with phenothiazines. Psychopharmacologia 28:309\u2013312","journal-title":"Psychopharmacologia"},{"key":"29_CR6","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/0165-1781(81)90030-5","volume":"4","author":"MB Bowers","year":"1981","unstructured":"Bowers MB, Heninger GR (1981) Cerebrospinal fluid homo vanillic acid patterns during neuroleptic treatment. Psychiatry Res 4: 285\u2013290","journal-title":"Psychiatry Res"},{"key":"29_CR7","first-page":"284","volume":"6","author":"MB Bowers","year":"1984","unstructured":"Bowers MB, Swigar ME, Jatlow PI, Goicoecha N (1984) Plasma catecholamine metabolites and early response to haloperidol. J Clin Psychiatry 6: 284\u2013251","journal-title":"J Clin Psychiatry"},{"key":"29_CR8","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/S0166-2236(84)80013-2","volume":"7","author":"BS Bunney","year":"1984","unstructured":"Bunney BS (1984) Antipsychotic drug effects on the electrical activity of dopaminergic neurons. Trends Neurosci 7: 212\u2013215","journal-title":"Trends Neurosci"},{"key":"29_CR9","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1001\/archpsyc.1963.01720150090010","volume":"9","author":"WE Bunney Jr","year":"1963","unstructured":"Bunney WE Jr, Hamburg DA (1963) Methods for reliable longitudinal observation of behavior. Arch Gen Psychiatry 9: 280\u2013294","journal-title":"Arch Gen Psychiatry"},{"key":"29_CR10","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1600-0773.1963.tb01730.x","volume":"20","author":"A Carlsson","year":"1963","unstructured":"Carlsson A, Lindqvist M (1963) Effect of chlorpromazine or haloperidol on formation of 3- methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol Toxicol 20: 140\u2013144","journal-title":"Acta Pharmacol Toxicol"},{"key":"29_CR11","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1111\/j.1600-0773.1983.tb03423.x","volume":"53","author":"WH Chang","year":"1983","unstructured":"Chang WH, Sheinin M, Burns RS, Linnoila M (1983) Rapid and simple determination of homovanillic acid in plasma using high performance liquid chromatography with electrochemical detection. Acta Pharmacol Toxicol 53: 275\u2013279","journal-title":"Acta Pharmacol Toxicol"},{"key":"29_CR12","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1126\/science.3854","volume":"192","author":"I Creese","year":"1976","unstructured":"Creese I, Burt DR, Snyder SH (1976) Dopamine receptor binding predicts clinical and pharmacologic potencies of antischizophrenic drugs. Science 192: 481\u2013483","journal-title":"Science"},{"key":"29_CR13","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1126\/science.3975630","volume":"227","author":"KL Davis","year":"1985","unstructured":"Davis KL, Davidson M, Mohs RC, Kendler KS, Davis BM, Johns CA, DeNegris Y, Horvath TG (1985) Plasma homovanillic acid concentrations and the severity of schizophrenic illness. Science 227: 1601\u20131602","journal-title":"Science"},{"key":"29_CR14","unstructured":"Diagnostic and Statistical Manual of Mental Disorders, 3rd edn (1980) American Psychiatric Association, Washington, DC"},{"key":"29_CR15","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1016\/0024-3205(82)90447-7","volume":"30","author":"KS Kendler","year":"1982","unstructured":"Kendler KS, Heninger GR, Roth RH (1982) Influence of dopamine agonists on plasma and brain levels of homovanillic acid. Life Sci 30: 2063\u20132069","journal-title":"Life Sci"},{"key":"29_CR16","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/0165-1781(83)90065-3","volume":"8","author":"KS Kendler","year":"1983","unstructured":"Kendler KS, Mohs RC, Davis KL (1983) The effects of diet and physical activity on plasma homovanillic acid in normal human subjects. Psychiatry Res 8: 215\u2013223","journal-title":"Psychiatry Res"},{"key":"29_CR17","first-page":"255","volume-title":"Neuroleptics, neurochemical, behavioral and clinical perspectives","author":"HY Meltzer","year":"1983","unstructured":"Meltzer HY, Kane JM, Kalakowska T (1983) Plasma levels of neuroleptics, prolactin levels, and clinical response. In: Coyle JT, Enna SJ (eds) Neuroleptics, neurochemical, behavioral and clinical perspectives. Raven, New York, pp 255\u2013279"},{"key":"29_CR18","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","volume":"10","author":"JE Overall","year":"1961","unstructured":"Overall JE, Gorham DE (1961) The brief psychiatric rating scale. Psychol Rep 10: 799\u2013812","journal-title":"Psychol Rep"},{"key":"29_CR19","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1126\/science.6474162","volume":"225","author":"D Pickar","year":"1984","unstructured":"Pickar D, Labarca R, Linnoila M, Roy A, Hommer D, Everett D, Paul SM (1984) Neuroleptic- induced decrease in plasma homovanillic acid and antipsychotic activity in schizophrenic patients. Science 225: 957\u2013957","journal-title":"Science"},{"key":"29_CR20","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/archpsyc.1986.01800070059008","volume":"43","author":"D Pickar","year":"1985","unstructured":"Pickar D, Labarca R, Doran AR, Wolkowitz OM, Roy A, Breier A, Linnoila M, Paul SM (1985) Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients: correlation with psychosis and response to neuroleptic treatment. Arch Gen Psychiatry 43: 669\u2013676","journal-title":"Arch Gen Psychiatry"},{"key":"29_CR21","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1126\/science.1166321","volume":"190","author":"RM Post","year":"1975","unstructured":"Post RM, Goodwin FK (1975) Time-dependent effects of phenothiazines on dopamine turnover in psychiatric patients. Science 190: 488\u2013499","journal-title":"Science"},{"key":"29_CR22","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0014-2999(84)90478-3","volume":"103","author":"E Richelson","year":"1984","unstructured":"Richelson E, Nelson A (1984) Antagonism by neuroleptics of neurotransmitter receptors of normal human brain in vitro. Eur J Pharmacol 103: 197\u2013204","journal-title":"Eur J Pharmacol"},{"key":"29_CR23","first-page":"119","volume-title":"Neuroleptics: neurochemical, behavioral and clinical perspectives","author":"RH Roth","year":"1983","unstructured":"Roth RH (1983) Neuroleptics: functional neurochemistry. In: Coyle JT, Enna SJ (eds) Neuroleptics: neurochemical, behavioral and clinical perspectives. Raven, New York, pp 119\u2013156"},{"key":"29_CR24","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/0022-3956(74)90075-2","volume":"11","author":"G Sedvall","year":"1974","unstructured":"Sedvall G, Fyro B, Nyback H, Wiesel FH, Wode-Helgodt B (1974) Mass fragmentographic determinations of HVA in lumbar CSF of schizophrenic patients during treatment with antipsychotic drugs. J Psychiatry Res 11: 75\u201380","journal-title":"J Psychiatry Res"},{"key":"29_CR25","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/261717a0","volume":"261","author":"P Seeman","year":"1976","unstructured":"Seeman P, Lee T, Chau-Wong M, Wong K (1976) Antipsychotic drug doses and neuroleptic\/ dopamine receptors. Nature 261: 717\u2013719","journal-title":"Nature"},{"key":"29_CR26","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1016\/0024-3205(83)90370-3","volume":"32","author":"DE Sternberg","year":"1983","unstructured":"Sternberg DE, Heninger GR, Roth RH (1983) Plasma homovanillic acid as an index of brain dopamine metabolism: enhancement with debrisoquin. Life Sci 32: 2447\u20132452","journal-title":"Life Sci"},{"key":"29_CR27","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1016\/0024-3205(80)90430-0","volume":"27","author":"AC Swann","year":"1980","unstructured":"Swann AC, Maas JW, Hattox SE, Landis H (1980) Catecholamine metabolites in human plasma as indices of brain function: effects of debrisoquin. Life Sci 27: 1857\u20131862","journal-title":"Life Sci"}],"container-title":["Clinical Pharmacology in Psychiatry"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-71288-3_29.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T18:06:36Z","timestamp":1606241196000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-642-71288-3_29"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1987]]},"ISBN":["9783642712906","9783642712883"],"references-count":27,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-71288-3_29","relation":{},"subject":[],"published":{"date-parts":[[1987]]}}}